How many insider trades does FilingIQ track for MYO?

FilingIQ tracks 292 Form 4 insider transactions for MYO (MYOMO, INC.), covering filings from Jun 9, 2017 onwards. 8 of those were filed in the last 90 days.

Are MYO insiders net buyers or net sellers?

Across the full Form 4 history for MYO, 42 transactions (14%) were open-market purchases and 18 (6%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MYO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MYO in?

MYOMO, INC. (MYO) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $26.54M.

MYO insider trading

NYSE American Healthcare

MYOMO, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

292

Last 90 days

Buys / sells

14% / 6%

Market cap

$26.54M

About MYOMO, INC.

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

Company website: myomo.com

MYO insider activity at a glance

FilingIQ has scored 292 insider transactions for MYO since Jun 9, 2017. The most recent filing in our index is dated Apr 14, 2026.

Across the full history, 42 open-market purchases and 18 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MYO insider trades is 57.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MYO trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for MYO?: FilingIQ tracks 292 Form 4 insider transactions for MYO (MYOMO, INC.), covering filings from Jun 9, 2017 onwards. 8 of those were filed in the last 90 days.
Are MYO insiders net buyers or net sellers?: Across the full Form 4 history for MYO, 42 transactions (14%) were open-market purchases and 18 (6%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MYO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MYO in?: MYOMO, INC. (MYO) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $26.54M.

Methodology & sources

Every MYO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.